1. Research and Development in Oncology: Researchers can use cGEDs to explore potential relationships between gene expressions and drug responses, aiding in the development of targeted therapies.
2. Clinical Decision Support: Clinicians can employ cGEDs to understand the potential efficacy of drugs for specific cancer types, considering the patient's genetic makeup.
3. Educational Tool: Educators and students in medical and biological sciences can use cGEDs as a learning tool to understand the complexities of gene-drug interactions in cancer treatment.

1. Data Dependency: The accuracy and relevance of the insights depend heavily on the datasets used. Any limitations or biases in the GDSC datasets can impact the results.
2. Not a Standalone Diagnostic Tool: While cGEDs provides valuable insights, it should be used in conjunction with other diagnostic tools and clinical judgment.
3. Generalizability: The correlations found may not apply to all patient populations or cancer types, as genetic diversity and environmental factors can influence drug responses.

cGEDs is grounded in data from the GDSC1 and GDSC2 datasets, reputable sources in the field of cancer research. The correlations calculated by the app are based on established bioinformatics methods, ensuring a data-driven and scientifically sound approach. The use of publicly accessible data repositories enhances the credibility and comprehensiveness of the analysis.

The cGEDs app was conceived and developed with the goal of enhancing cancer treatment strategies through personalized medicine. Recognizing the diversity and complexity of cancer types and patient genetic profiles, the app aims to bridge the gap between raw genomic data and actionable clinical insights. The developers acknowledge the challenges in cancer treatment and strive to contribute a tool that aids in making more informed decisions regarding drug selection, ultimately aiming to improve patient outcomes in oncology.